On the

Press Releases

Dec 08, 2020 Assembly Biosciences to Wind-Down Microbiome Program
View HTML
PDF Version
Dec 04, 2020 Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
View HTML
PDF Version
Nov 17, 2020 Assembly Biosciences Appoints Nicole S. White, PhD, as Senior Vice President of Pharmaceutical Development and Manufacturing
View HTML
PDF Version
Nov 16, 2020 Assembly Biosciences and Door Pharmaceuticals Sign Collaboration and Option Agreement to Develop a Novel Class of HBV Core Protein Modulators
View HTML
PDF Version
Nov 13, 2020 Assembly Biosciences Presents Data from HBV Core Inhibitor Programs in Poster Sessions at the 2020 AASLD The Liver Meeting Digital Experience™
View HTML
PDF Version
Nov 06, 2020 Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
View HTML
PDF Version
Nov 05, 2020 Assembly Biosciences Reports Third Quarter 2020 Financial Results and Business Update
View HTML
PDF Version
Nov 05, 2020 Assembly Biosciences Provides Update on the Ongoing Phase 2 Extension Study of Vebicorvir in Patients with Chronic Hepatitis B Virus Infection
View HTML
PDF Version
Nov 02, 2020 Multiple Abstracts Highlighting Assembly Biosciences’ Hepatitis B Core Inhibitor Development Programs Accepted for Presentation at the 2020 AASLD The Liver Meeting Digital Experience™
View HTML
PDF Version
Oct 20, 2020 Assembly Biosciences Appoints Gina Consylman to Board of Directors
View HTML
PDF Version